Insider Transactions in Q3 2022 at Vir Biotechnology, Inc. (VIR)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2022
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
122,564
-0.28%
|
$3,309,228
$27.99 P/Share
|
|
Aug 15
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+7.61%
|
-
|
|
Aug 15
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+7.28%
|
-
|
|
Aug 15
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.87%
|
-
|
|
Aug 15
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
2,952
+7.29%
|
-
|
|
Aug 15
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
14,551
+7.25%
|
-
|
|
Aug 15
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.87%
|
-
|
|
Aug 12
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+8.24%
|
-
|
|
Aug 12
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+7.85%
|
-
|
|
Aug 12
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.79%
|
-
|
|
Aug 12
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
2,952
+7.86%
|
-
|
|
Aug 12
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
14,551
+7.81%
|
-
|
|
Aug 12
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.79%
|
-
|
|
Aug 09
2022
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
78,093
+12.27%
|
$390,465
$5.96 P/Share
|
|
Aug 08
2022
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,915
-1.22%
|
$537,450
$30.29 P/Share
|
|
Jul 20
2022
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.36%
|
$150,000
$30.0 P/Share
|
|
Jul 20
2022
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+3.25%
|
$5,000
$1.57 P/Share
|
|
Jul 11
2022
|
Saira Ramasastry Director |
SELL
Open market or private sale
|
Direct |
5,000
-38.19%
|
$150,000
$30.0 P/Share
|
|
Jul 11
2022
|
Saira Ramasastry Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+27.64%
|
$60,000
$12.76 P/Share
|
|
Jul 08
2022
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,915
-0.6%
|
$519,535
$29.22 P/Share
|